biotome_logo_approved_v101_whiteText.png
  • Home

  • Technology

  • Services

  • News

  • About

  • Contact

  • More

    Use tab to navigate through the menu items.

    Built on the discovery of markers that identify high stomach cancer risk, Biotome was founded to benefit patients around the world.

    Biotome is developing antibody tests using next-generation technology and precision immunology to address the problems of traditional serology tests.

    Scientist on Tablet

    The Biotome Team

    headshot_SamuelLundin_01.png

    Dr Samuel Lundin

    Director / CEO

    Samuel is an Immunologist, was a Professor in Biomedicine at University of Gothenburg... 

    headshot_AlmaFulurija_01.png

    Dr Alma Fulurija

    Director

    Alma has a PhD in Immunology, and almost 20 years of experience in biotech... 

    headshot_HenrikLundin_02.png

    Henrik Lundin

    Chairman

    Henrik has a very strong management experience from more than 30 years in IT and...

    headshot_CarelSmit_01.png
    headshot_BarryMarshall_01.png
    headshot_LukeMarshall_01.png

    Carel Smit

    Dr Barry Marshall

    Luke Marshall

    Director

    Carel is a former S&P Global 100 Intellectual Property counsel, and a medical...

    Co-founder/Advisor

    Barry was awarded the Nobel Prize in Medicine 2005 for the discovery of the bacterium...

    Head of Data Science

    Luke has decades of expertise in data science and software development in oil exploration, MedTech and...

    Biotome Pty Ltd

    Harry Perkins Insitute of Medical Research

    6 Verdun Street, Nedlands, WA, Australia

    +61 479 072 369

    ©2022 by Biotome Pty Ltd.